Visgeneer Inc. (TPEX:4197)
Taiwan · Delayed Price · Currency is TWD 10.55
-1.55 (-12.81%)
Sep 11, 2026, 1:52 PM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 318.41 million as of September 11, 2026. Its market cap has decreased by -5.80% in one year.
Market Cap
318.41M
Enterprise Value
375.41M
Revenue
170.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.55
ChartMarket Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 318.41M, a decrease of -64.57%. That is a compound annual growth rate of -7.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 318.41M | 8.76% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neith | 793.51M |
| Lukas Biomedical | 732.80M |
| BioLASCO Taiwan | 729.94M |
| MegaPro Biomedical | 698.99M |
| SynCore Biotechnology Co.,Ltd | 664.62M |
| Taiwan Advance Bio-Pharmaceutical | 645.30M |
| LAUNXP Biomedical | 584.19M |
| Vectorite Biomedical | 544.95M |